1
|
Migault C, Kanagaratnam L, Hentzien M, Giltat A, Nguyen Y, Brunet A, Thibault M, Legall A, Drame M, Bani-Sadr F. Effectiveness of an education health programme about Middle East respiratory syndrome coronavirus tested during travel consultations. Public Health 2019; 173:29-32. [PMID: 31252151 PMCID: PMC7118754 DOI: 10.1016/j.puhe.2019.05.017] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Revised: 05/02/2019] [Accepted: 05/15/2019] [Indexed: 10/29/2022]
Abstract
OBJECTIVE We aimed to evaluate the level of knowledge of Middle East respiratory syndrome coronavirus (MERS-CoV) among Hajj pilgrims before and after an education health programme during international vaccine consultations in France. STUDY DESIGN A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital between July 2014 and October 2015. METHODS Consecutive adults (>18 years old) who attended for pre-Hajj meningococcal vaccination were eligible to complete an anonymous questionnaire with closed answers to evaluate their level of knowledge about MERS-CoV. To evaluate the effectiveness of the information given during the consultation, the same questionnaire was completed by the Hajj pilgrim before and after the consultation, where the information about MERS-CoV was provided. RESULTS Among 82 Hajj pilgrim adults enrolled in the study, less than 25% were aware of the routes of transmission, symptoms and preventive behaviours to adopt abroad or in case of fever. Pilgrims had a higher rate of correct responses on each question at the time they completed the second questionnaire, as compared with the first, with 11 of 13 questions answered significantly better after delivery of educational information about MERS-CoV. However, although the rate of correct answers to the questions about routes of transmission, symptoms, preventive behaviours to adopt in case of fever and time delay between return and potential MERS-CoV occurrence increased significantly after receiving the information, the rates remained below 50%. CONCLUSION Information given during travel consultations significantly increases the general level of knowledge, but not enough to achieve epidemic control.
Collapse
Affiliation(s)
- C Migault
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - L Kanagaratnam
- CHU Reims, Hôpital Robert Debré, Pôle Recherche et Innovations, Unité d'aide méthodologique, Reims, F-51092, France
| | - M Hentzien
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - A Giltat
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - Y Nguyen
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France; Université de Reims Champagne-Ardenne, Faculté de médecine, EA-4684 / SFR CAP-SANTE, Reims, F-51095, France
| | - A Brunet
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - M Thibault
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - A Legall
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France
| | - M Drame
- CHU Reims, Hôpital Robert Debré, Pôle Recherche et Innovations, Unité d'aide méthodologique, Reims, F-51092, France; Université de Reims Champagne-Ardenne, Faculté de médecine, EA 3797, Reims, F-51095, France
| | - F Bani-Sadr
- CHU Reims, Hôpital Robert Debré, Unité des Maladies Infectieuses et Tropicales, Reims, F-51092, France; Université de Reims Champagne-Ardenne, Faculté de médecine, EA-4684 / SFR CAP-SANTE, Reims, F-51095, France.
| |
Collapse
|
2
|
Afenjar A, Billette De Villemeur T, Chabrol B, Gras D, Legall A, Mochel F, Sedel F, Rodriguez D, Burglen L. Phénotype clinique reconnaissable des neurodegeneration with brain iron accumulation (NBIA) liées aux mutations du gène C19ORF12. Arch Pediatr 2013. [DOI: 10.1016/j.arcped.2013.01.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
3
|
Laferrere B, Nguyen M, Bonhomme G, Legall A, Basdevant A, Guy-Grand B. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin. Behav Neurosci 1991. [PMID: 1815620 DOI: 10.1037//0735-7044.105.5.707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The role of cholecystokinin (CCK) in food intake was investigated in rats by using BIM-18216, a novel CCK receptor antagonist. In rats fed 6 hr/day, BIM-18216 antagonized the reduction of food intake induced by exogenous CCK octapeptide (CCK-8; 4 micrograms/kg) in a dose-dependent manner and had a maximum effect at 1 mg/kg. BIM-18216 did not antagonize the effect of bombesin on food intake and showed some degree of specificity. BIM-18216 was not able to prevent the effect of endogenous CCK at the beginning of the feeding period. These data demonstrate that BIM-18216 is a potent CCK-specific antagonist. These results also suggest that endogenous and exogenous CCK could act by different regulating pathways.
Collapse
Affiliation(s)
- B Laferrere
- Service de Médecine et Nutrition, Hôpital Hôtel-Dieu de Paris, France
| | | | | | | | | | | |
Collapse
|
4
|
Laferrere B, Nguyen M, Bonhomme G, Legall A, Basdevant A, Guy-Grand B. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin. Behav Neurosci 1991; 105:707-11. [PMID: 1815620 DOI: 10.1037/0735-7044.105.5.707] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The role of cholecystokinin (CCK) in food intake was investigated in rats by using BIM-18216, a novel CCK receptor antagonist. In rats fed 6 hr/day, BIM-18216 antagonized the reduction of food intake induced by exogenous CCK octapeptide (CCK-8; 4 micrograms/kg) in a dose-dependent manner and had a maximum effect at 1 mg/kg. BIM-18216 did not antagonize the effect of bombesin on food intake and showed some degree of specificity. BIM-18216 was not able to prevent the effect of endogenous CCK at the beginning of the feeding period. These data demonstrate that BIM-18216 is a potent CCK-specific antagonist. These results also suggest that endogenous and exogenous CCK could act by different regulating pathways.
Collapse
Affiliation(s)
- B Laferrere
- Service de Médecine et Nutrition, Hôpital Hôtel-Dieu de Paris, France
| | | | | | | | | | | |
Collapse
|